Alan E. Wakeling
- Genetics top 1%
- Estrogen and related hormone effects 28
- Oncology top 2%
- HER2/EGFR in Cancer Research 15
- Cancer Treatment and Pharmacology 3
- Cancer Research top 5%
- Toxicology top 2%
- Molecular Biology top 5%
- PI3K/AKT/mTOR signaling in cancer 4
-
- Inflammatory mediators and NSAID effects 7
- Pharmacogenetics and Drug Metabolism 4
-
- Computational Drug Discovery Methods 3
-
- Growth Hormone and Insulin-like Growth Factors 3
- Co-authors
- Jean BowlerRobert I. NicholsonDenise BarrowJulia M.W. GeeAnthony HowellCharles MorrisC. Kent OsborneIain R. Hutcheson
- Cited by
- GeneticsOncologyCancer Research
- Journals
- Breast Cancer Research and Treatment (5 papers)International Journal of Cancer (4 papers)Cancer Chemotherapy and Pharmacology (3 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Alan E. Wakeling
43 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 102
- Genetics 1.6k
- Oncology 1.2k
- Cancer Research 458
- Toxicology 98
- Molecular Biology 1.5k
Countries citing papers authored by Alan E. Wakeling
This map shows the geographic impact of Alan E. Wakeling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan E. Wakeling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan E. Wakeling more than expected).
Fields of papers citing papers by Alan E. Wakeling
This network shows the impact of papers produced by Alan E. Wakeling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan E. Wakeling. The network helps show where Alan E. Wakeling may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Alan E. Wakeling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 93 | |
| 2 | 2003 | 432 | |
| 3 | 2003 | 138 | |
| 4 | 2002 | 17 | |
| 5 | 2001 | 92 | |
| 6 | 2000 | 338 | |
| 7 | 1995 | 32 | |
| 8 | 1995 | 76 | |
| 9 | 1995 | 44 | |
| 10 | 1994 | 98 | |
| 11 | 1993 | 71 | |
| 12 | 1993 | 13 | |
| 13 | 1993 | 111 | |
| 14 | 1993 | 17 | |
| 15 | 1992 | 216 | |
| 16 | 1989 | 24 | |
| 17 | 1989 | 61 | |
| 18 | 1989 | 159 | |
| 19 | 1988 | 59 | |
| 20 | 1973 | 23 |
About Alan E. Wakeling
Alan E. Wakeling is a scholar working on Genetics, Oncology and Pharmacology, having authored 44 papers that have together received 3.1k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (28 papers), HER2/EGFR in Cancer Research (15 papers), Inflammatory mediators and NSAID effects (7 papers), Pharmacogenetics and Drug Metabolism (4 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Computational Drug Discovery Methods (3 papers), Cancer Treatment and Pharmacology (3 papers) and Growth Hormone and Insulin-like Growth Factors (3 papers). The work is most often cited by research in Genetics (1.6k citations), Oncology (1.2k citations) and Cancer Research (458 citations). Alan E. Wakeling has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Jean Bowler, Robert I. Nicholson, Denise Barrow, Julia M.W. Gee, Anthony Howell, Charles Morris, C. Kent Osborne, Iain R. Hutcheson, Janice M. Knowlden and Tracie‐Ann Madden. Their work appears in journals such as Breast Cancer Research and Treatment, International Journal of Cancer, Cancer Chemotherapy and Pharmacology, Cancer and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.